Together, these results indicated that CLDN4 is a direct GRHL2 target while CDH1, ZEB1, or ZEB2 are unlikely to represent direct GRHL2 target genes in luminal breast cancer cells. This evidence concerns the gene ZEB1 and breast carcinoma.